Items where Author is "Hughes, Diana"

Item Type No Grouping

IMI work package 5: report 1:b:iii benefit - riskwave 1 case study report:Raptiva® (efalizumab). Micaleff, Alain; Callreus, Tornbjorn; Phillips, Lawrence D.; Hughes, Diana; Hockley, Kimberley; Wang, Nan; Luciani, David

IMI work package 5: report 2:b:ii benefit - riskwave 2 case study report: Rosiglitazone. Phillips, Lawrence D.; Amzal, Billy; Asiimwe, Alex; Chan, Edmond; Chen, Chen; Hughes, Diana; Juhaeri, Juhaeri; Micaleff, Alain; Mt-Isa, Shahrul; Noel, Becky; Shepherd, Susan; Wang, Nan

IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines. Hughes, Diana; Waddingham, Ed, A., J.; Mt-Isa, Shahrul; Goginsky, Alesia; Chan, Edmond; Downey, Gerald; Hallgreen, Christine E.; Hockley, Kimberley S.; Juhaeri, Juhaeri; Lieftucht, Alfons; Metcalfe, Marilyn, A.; Noel, Rebecca, A.; Phillips, Lawrence D.; Ashby, Deborah; Micaleff, Alain

Review of visualisation methods for therepresentation of benefit-risk assessment ofmedication: stage 2 of 2. Mt-Isa, Shahrul; Hallgreen, Christine, E.; Asiimwe, Alex; Downey, Gerry; Genov, Georgy; Hermann, Richard; Hughes, Diana; Lieftucht, Alfons; Noel, Rebecca; Peters, Ruth; Phillips, Lawrence D.; Shepherd, Susan; Micaleff, Alain; Ashby, Deborah; Tzoulak, Ioanna